MicroRNA-1185 Promotes Arterial Stiffness though Modulating VCAM-1 and E-Selectin Expression

Background/Aims: Atherosclerosis is the primary cause of cardiovascular ischaemic events; arterial stiffness is a characteristic of the atherosclerotic process. MicroRNAs (miRNAs) have been revealed as crucial modulators of atherosclerosis. However, the role of arterial stiffness-related miRNAs in the atherosclerotic process is still unclear. Methods: Four hundred six participants from Northern China were enrolled in this study. Circulating miR-1185 and adhesion molecule levels were measured. Multiple linear regression models were used to evaluate the association of miR-1185 levels with brachial-ankle pulse wave velocity (baPWV) and adhesion molecule levels. A mediation analysis was also performed to examine the mediating effect. Cell adhesion molecule levels were measured in primary human umbilical vein endothelial cells (pHUVECs) and human umbilical vein smooth cells (HUVSMCs) transfected with miR-1185 or co-transfected with a miR-1185 inhibitor. Results: miR-1185 was independently correlated with arterial stiffness. A positive relationship between miR-1185 and vascular cell adhesion molecule-1 (VCAM-1) and E-selectin levels was observed. VCAM- 1 and E-selectin partially mediated the correlation between miR-1185 and arterial stiffness. miR-1185 induced a significant increase in the VCAM-1 and E-selectin levels in pHUVECs and HUVSMCs in vitro. According to our mechanistic analysis, VCAM-1 and E-selectin mediated miR-1185-induced arterial stiffening. Conclusions: miR-1185 modulated the expression of VCAM-1 and E-selectin to promote arterial stiffening, suggesting that miR-1185 plays a crucial role in the development of atherosclerosis and may serve as a novel therapeutic target for atherosclerosis.

[1]  A. Cai,et al.  The Relationship of Plasma miR-29a and Oxidized Low Density Lipoprotein with Atherosclerosis , 2016, Cellular Physiology and Biochemistry.

[2]  Hong-jin Wu,et al.  Microarray Expression Profile of Circular RNAs in Heart Tissue of Mice with Myocardial Infarction-Induced Heart Failure , 2016, Cellular Physiology and Biochemistry.

[3]  Songtao Li,et al.  Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway , 2016, Diabetologia.

[4]  Jing Jing,et al.  Atherosclerosis-Associated Endothelial Cell Apoptosis by MiR-429-Mediated Down Regulation of Bcl-2 , 2015, Cellular Physiology and Biochemistry.

[5]  Jing Jing,et al.  Endothelial Cell Autophagy in Atherosclerosis is Regulated by miR-30-Mediated Translational Control of ATG6 , 2015, Cellular Physiology and Biochemistry.

[6]  Hong Jiang,et al.  MiR-17-5p as circulating biomarkers for the severity of coronary atherosclerosis in coronary artery disease. , 2015, International journal of cardiology.

[7]  Shao-Lin He,et al.  MicroRNA-21 Negatively Regulates Treg Cells Through a TGF-β1/Smad-Independent Pathway in Patients with Coronary Heart Disease , 2015, Cellular Physiology and Biochemistry.

[8]  S. Juo,et al.  MicroRNA-765 influences arterial stiffness through modulating apelin expression , 2015, Molecular and Cellular Endocrinology.

[9]  Lixia Yang,et al.  MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1 , 2015, Cellular Physiology and Biochemistry.

[10]  H. Uzun,et al.  Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension , 2015, Clinical and experimental hypertension.

[11]  Y. Li,et al.  The Harbin Cohort Study on Diet, Nutrition and Chronic Non-Communicable Diseases: Study Design and Baseline Characteristics , 2015, PloS one.

[12]  Y. Li,et al.  Increased hemoglobin A1c threshold for prediabetes remarkably improving the agreement between A1c and oral glucose tolerance test criteria in obese population. , 2015, The Journal of clinical endocrinology and metabolism.

[13]  Maoquan Li,et al.  A Dysregulated MicroRNA-26a/EphA2 Axis Impairs Endothelial Progenitor Cell Function via the p38 MAPK/VEGF Pathway , 2015, Cellular Physiology and Biochemistry.

[14]  S. Boulkroun,et al.  Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and Atherosclerosis in Mice , 2014, Circulation research.

[15]  A. Schober,et al.  The role of microRNAs in arterial remodelling , 2012, Thrombosis and Haemostasis.

[16]  E. Lakatta,et al.  Role of Inflammation in the Pathogenesis of Arterial Stiffness , 2012, Yonsei medical journal.

[17]  T. Lehtimäki,et al.  miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. , 2011, Atherosclerosis.

[18]  J. Freedman,et al.  The distribution of circulating microRNA and their relation to coronary disease , 2010, F1000Research.

[19]  T. Michel,et al.  Sphingosine-1-phosphate and modulation of vascular tone. , 2009, Cardiovascular research.

[20]  Yariv Yogev,et al.  Serum MicroRNAs Are Promising Novel Biomarkers , 2008, PloS one.

[21]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[22]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[23]  Weibin Shi,et al.  siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migration. , 2008, Atherosclerosis.

[24]  C. McNamara,et al.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[25]  C. D. A. Stehouwer,et al.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease , 2008, Diabetologia.

[26]  Stefanie Dimmeler,et al.  Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.

[27]  Jordan S. Pober,et al.  Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells , 2007, Circulation research.

[28]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[29]  B. Gewertz,et al.  Vascular Dysfunction in Ischemia-Reperfusion Injury , 2005, Annals of vascular surgery.

[30]  D. Kass,et al.  Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T. Sawamura,et al.  Induction of Endothelin-1 Production in Endothelial Cells Via Co-Operative Action Between CD40 and Lectin-like Oxidized LDL Receptor (LOX-1) , 2004, Journal of cardiovascular pharmacology.

[32]  M. Jacob.  Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  P. Crean,et al.  Prediction of cardiovascular risk using soluble cell adhesion molecules. , 2002, European heart journal.

[34]  A. Brasier,et al.  Vascular inflammation and the renin-angiotensin system. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[35]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[36]  P. Devillier,et al.  Vascular Biology of the Isoprostanes , 2001, Journal of Vascular Research.

[37]  A. Hofman,et al.  Association Between Arterial Stiffness and Atherosclerosis: The Rotterdam Study , 2001, Stroke.

[38]  J. Cohn.  Vascular wall function as a risk marker for cardiovascular disease. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[39]  J. Loscalzo,et al.  Cellular adhesion molecules and atherogenesis. , 1999, The American journal of medicine.

[40]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[41]  P. McIntyre,et al.  Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability. , 1999, The American journal of pathology.

[42]  A. Dart,et al.  Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. , 1998, Hypertension.

[43]  John C. Lee,et al.  p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. , 1997, Biochemical and biophysical research communications.

[44]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules: NF‐κB and cytokine‐inducible enhancers , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  L. Ghiadoni,et al.  Aging and endothelial function in normotensive subjects and patients with essential hypertension. , 1995, Circulation.

[46]  K. Kent,et al.  Additions and Corrections to Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. , 1994, The Journal of Biological Chemistry.

[47]  M. Davies,et al.  The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis , 1993, The Journal of pathology.

[48]  R. Virmani,et al.  Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. , 1991, The American journal of pathology.

[49]  T. Lüscher,et al.  Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. , 1991, Circulation.

[50]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[51]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[52]  S. Sasayama,et al.  Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. , 1989, Circulation.

[53]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[54]  K. Walton,et al.  The pathogenesis of atherosclerosis of the mitral and aortic valves , 1970, The Journal of pathology.

[55]  櫻井 華奈子.  Induction of endothelin-1 production in endothelial cells via co-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1) , 2004 .

[56]  D. Webb,et al.  Pulse wave analysis and arterial stiffness. , 1998, Journal of cardiovascular pharmacology.

[57]  K. Kent,et al.  Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. , 1995, The Journal of biological chemistry.

[58]  D. Kass,et al.  Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly Matrix Metalloproteinases: Regulation and Dysregulation in the Failing Heart Matrix Metallopro , 2002 .

[59]  M. Nugent.  Cancer Management and Research Dovepress Microrna Function and Dysregulation in Bone Tumors: the Evidence to Date , 2022 .